Sunesis Pharmaceuticals, Inc. announced the appointment of Joseph I. DePinto to the newly created position of Executive Vice President and Chief Commercial Officer. Mr. DePinto brings over two decades of experience in global commercial operations, including the leadership of the commercial, marketing and strategic development efforts behind a number of prominent oncology products. Prior to joining Sunesis, Mr. DePinto was Executive Vice President, Global Commercial Operations at Dendreon Corporation, where he was responsible for all sales, marketing, and market access teams in the U.S. and globally.